MALLINCKRODT PLC

History

YearDetail
1867 The company was founded.
1882 Incorporates in Missouri as Mallinckrodt Chemical Works.
1884 Establishes its first office in New York City.
1924 Introduced iodeikon to the scientific community.
1950 Introduces UROKON SODIUM.
1962 The company acquired Van Pelt & Brown.
1966 Acquires Nuclear Consultants, Inc. of Maryland Heights, Missouri.
1982 Avon acquired Mallinckrodt.
1986 The company was acquired by the International Minerals and Chemical Corporation.
1995 Launched the company's first generic pharmaceutical.
2000 Mallinckrodt was acquired by Tyco International.
2007 Tyco Healthcare got separated from Tyco International and renamed itself as Covidien, an independent company.
2012 The company acquired CNS Therapeutics and its intrathecal therapy products.
2015 The company acquired Ikaria, Inc.
2019 The company completed the sales of wholly owned subsidiary BioVectra Inc.
2021 Received FDA approval of StrataGraft.
2022 Received FDA approval for Terlivaz.
2024 The company got U.S. FDA approval for supplemental new drug application for Acthar Gel.